Search by Drug Name or NDC

    NDC 52937-0003-40 Vascepa 500 mg/1 Details

    Vascepa 500 mg/1

    Vascepa is a ORAL CAPSULE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Amarin Pharma Inc.. The primary component is ICOSAPENT ETHYL.

    Product Information

    NDC 52937-0003
    Product ID 52937-003_3cbbd4ee-5c31-4ed9-a39c-01b3529967f9
    Associated GPIs 39500035100110
    GCN Sequence Number 076660
    GCN Sequence Number Description icosapent ethyl CAPSULE 0.5 GRAM ORAL
    HIC3 M4E
    HIC3 Description LIPOTROPICS
    GCN 42365
    HICL Sequence Number 039613
    HICL Sequence Number Description ICOSAPENT ETHYL
    Brand/Generic Brand
    Proprietary Name Vascepa
    Proprietary Name Suffix n/a
    Non-Proprietary Name icosapent ethyl
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form CAPSULE
    Route ORAL
    Active Ingredient Strength 500
    Active Ingredient Units mg/1
    Substance Name ICOSAPENT ETHYL
    Labeler Name Amarin Pharma Inc.
    Pharmaceutical Class n/a
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA202057
    Listing Certified Through 2024-12-31

    Package

    NDC 52937-0003-40 (52937000340)

    NDC Package Code 52937-003-40
    Billing NDC 52937000340
    Package 240 CAPSULE in 1 BOTTLE (52937-003-40)
    Marketing Start Date 2016-09-16
    NDC Exclude Flag N
    Pricing Information
    Price Per Unit 1.67229
    Pricing Unit EA
    Effective Date 2023-12-20
    NDC Description VASCEPA 0.5 GM CAPSULE
    Pharmacy Type Indicator C/I
    OTC N
    Explanation Code 2
    Classification for Rate Setting B
    As of Date 2024-02-21
    This pricing file, entitled the NADAC (National Average Drug Acquisition Cost) files, provide state Medicaid agencies with covered outpatient drug prices by averaging survey invoice prices from retail community pharmacies across the United States. These pharmacies include independent retail community pharmacies and chain pharmacies. The prices are updated on a weekly and monthly basis